Company

Akeso Biopharma Reports First Positive Earnings in H1 2023 Financial Results

CompanyMedical Device

MicroPort MedBot’s SkyWalker Orthopedic Surgery Robot Gains TGA Approval in Australia

Policy / Regulatory

CDE Releases Draft Guidelines for Clinical Pharmacology Research of Chemical Modified Drugs

CompanyDeals

Baidu Health Partners with GSK for Shingles Disease Education Programs in China

CompanyDrug

Transcenta Holdings Gets CDE Approval for Phase II Study of TST002 for Bone Density

CompanyDrug

Zelgen Biopharmaceuticals’ ZG006 Earns NMPA Approval for Clinical Trials in Solid Tumors

CompanyDeals

Mabwell Secures Licensing Deal with Morocco’s Sothema for Biosimilar Humira

CompanyDrug

Shanghai Benemae’s Benaglutide Approved by NMPA for Adult Weight Management in China

CompanyDrug

Nanjing Leads Biolabs’ LBL-034 Secures Clinical Trial Approvals from NMPA and FDA

CompanyDeals

Sanofi to Boost CHC Unit with Full Acquisition of US Health Brand Qunol

CompanyDeals

AstraZeneca’s Alexion Secures Gene Therapy Portfolio in Deal with Pfizer

Company

AstraZeneca’s H1 2023 Financials Show 4% YOY Revenue Growth, Oncology and R&I Drive Sales